immunoglobulin e fs - grupo biosys · r2 diluent vol 0 calc.methd. mstd sample vol (s) 1,5 qualit....
TRANSCRIPT
January 2007/2
Immunoglobulin E FS
ADVIA 1200 – CHEMISTRY PARAMETERS
Analytical conditions Sub-analy. conditions
R1 volume 60 Name IgE
R2e volume 0 Digits 1
R2 volume 30 M-wave L. 570
R1 diluent vol 0 S-wave.L
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. MSTD
Sample Vol (S) 1,5 Qualit. Judge Not do
Sample Vol (U) 1,5 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 41
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 22
Sample Type Serum S-DET.P.r 23
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1,5 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Prozone Prozone formula
Reaction sample volume 1,5 Prozone limit 1,8
Diluent method No dilution Prozone judge Upper limit
Undiluted sample volume 0 Judge limit 9,999
Diluent volume 0,000 M-DET.P.m 34
Diluent position 0 M-DET.P.n 35
Diluent volume from RPP 0,000 S-DET.P.p 0
Rerun conditions set S-DET.P.r 0
Absorbance limit (u) D1
Absorbance limit (d) D2 Endpoint method
Effect.nbr.o.pnts (n) Re.absorb (u) 0,38
Abnormal val.limit (h) D1 Re.absorb (d) 0,012
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1,5 Serum reac.smp.vol (u) 1,5
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 3 Serum reac.smp.vol (u) 3
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 3 Dilute 3
Serum reac.smp.vol (u) 1,5 Serum reac.smp.vol (u) 1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 10 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
January 2007/2
Standard settings MULTI-STD
Formula Spline correction Axis conv No convert
Blank passes Points 6
Pos. FV Reac.samp. vol.
Dil. Method Dil.samp. vol.
Diluent volume
Diluent posit.
Diluent volume
STD H STD L
BLK 0 1,5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
1 50 1,5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
2 100 1,5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
3 200 1,5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
4 500 1,5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
5 1000 1,5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
6 No dilution 0,000 0,000 0 0,000 9,999 -9,999
7 No dilution 0,000 0,000 0 0,000 9,999 -9,999
8 No dilution 0,000 0,000 0 0,000 9,999 -9,999
9 No dilution 0,000 0,000 0 0,000 9,999 -9,999
Order information Cat. No. 1 7239 .. .. …
Notes
1. Please refer to the package insert for Immunoglobulin E FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
November 2008/1
Uric Acid FS TBHBA
Cat. No 1 3021.........
Notes 1. Please refer to the package insert for Uric Acid TBHBA FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name UA
R2e volume 0 Digits 1
R2 volume 20 M-wave L. 505
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 2 Qualit. Judge Not do
Sample Vol (U) 2 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 18
Sample Type Serum S-DET.P.r 19
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 2 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u)
Diluent volume from RPP 0,000 Blank (d)
Sample Type Urine Sample (u)
Dilution specification Do Sample (d)
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 2 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 10 Serum reac.smp.vol (u) 10
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
November 2008/1
APLICAÇÕES Advia 1200
ALBUMINA DIASYS
Analytical conditions
R1 volume 100.0 Sub Param. 46 1 Up Down
R2e volume 0.00 Sub-analy-conditions Standards setting
R3 volume 0.00 Name Alb FV *** BLK-L -9.999 STD H -9.999 Multi-STD Setting
Digits 1 BLK-H 9.9999 STD L 9.9999 Error judge rare
R1 Extra vol H-wave.L. 596nm
R2 Extra vol S-wave.L. 694nm
R3 Extra vol Anal.mthd EPA
R1 diluent vol 0.00 Calc.mthd STD
R2e diluent vol 0.00
Quali.judg Not do
R3 diluent vol 0.00 CCalculation method setting
Sample Vol( S ) 1,0 M-DET.P.1 0 S-DETP.p. 0 Reac.typ Inc
Sample vol (U) 1,0 Qualit. Judgment set M-DET.P.m 41 S-DET.P.r 0 Reaction rate method
Real time correct form M-DET.P.n 42 Cycle 2
Reanalysis conditions Check D.P.I 0 Factor 2.0
Rerun conditions set Limit value 0.003 E2 corre Not do
Reagent 1 stir Weak Mark setting Variance 10.0 Blank(µ) 9.9999
Reagent 2e stir Weak Normal Value setting * Prozone Blank(d) -9.9999
Reagent 2 stir Weak Abnormal value setting Prozone form None Sample(µ) 9.9999
Reaction Time 10 min. Prozone limit 9.999 Sample
(d)
-9.9999
Prozone judge Upper limit
Anaysis item
Condition setting (M)
Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
IMA setting
Setting
Allowance
Metodologia: Verde de Bromocresol
Valor de Referência: 3,5 – 5,2 g/dL
Linearidade: 6,0 g/dL
Apresentação: 5 x 25 mL Rendimento 1014 testes
APLICAÇÕES Advia 1200
AMILASE DIASYS
Analytical conditions
R1 volume 80.00 Sub Param. 46 1 Up Down
R2e volume 0.00 Sub-analy-conditions Standards setting
R3 volume 20.00 Name Ami
FV
6300 BLK-L -9.999 STD H -9.999 Multi-STD Setting
Digits 0 BLK-H 9.9999 STD L 9.9999 Error judge rare
R1 Extra vol H-wave.L. 410nm
R2 Extra vol S-wave.L. 694nm
R3 Extra vol Anal.mthd RRA
R1 diluent vol 0.00 Calc.mthd ABB
R2e diluent vol 0.00
Quali.judg Not do
R3 diluent vol 0.00 CCalculation method setting
Sample Vol( S ) 6,0 M-DET.P.1 25 S-DETP.p. 0 Reac.typ Inc
Sample vol (U) 6,0 Qualit. Judgment set M-DET.P.m 34 S-DET.P.r 0 Reaction rate method
Real time correct form M-DET.P.n 42 Cycle 2
Reanalysis conditions Check D.P.I 21 Factor 2.0
Rerun conditions set Limit value 0.003 E2 corre Not do
Reagent 1 stir Weak Mark setting Variance 10.0 Blank(µ) 0,2270
Reagent 2e stir Weak Normal Value setting * Prozone Blank(d) 0,0110
Reagent 2 stir Weak Abnormal value setting Prozone form None Sample(µ) 1,2000
Reaction Time 10 min. Prozone limit 9.999 Sample
(d)
0,0110
Prozone judge Upper limit
Anaysis item
Condition setting (M)
Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
IMA setting
Setting
Allowance
Metodologia: CNP G7
Valor de Referência: < 1000 U/L
Linearidade: 1000 U/L
Apresentação: 5 x 20 mL
1 x 25 mL Rendimento = 740 testes
February 2006/2
APOLIPOPROTEIN A1 FS
Cat. No 1 7102.........
Notes 1. Please refer to the package insert for Apoliporotein A1 FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name APO A1
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 570
R1 diluent vol 0 S-wave.L
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. MSTD
Sample Vol (S) 1 Qualit. Judge Not do
Sample Vol (U) 1 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 41
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 17
Sample Type Serum S-DET.P.r 18
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1 Serum reac.smp.vol (u) 1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
Standard settings MULTI-STD
Formula Logit Log 3 Axis conv No convert
Blank passes Points 5
Pos. FV Reac.smp.vol.
Dil. Method Dil.smp.vol.
Diluent volume
Diluent posit.
Diluent volume
STD H STD L
BLK 1 0 1 No dilution 0,000 0,000 0 0,000 9,999 -9,999
1 2 0.2 1 A dilution 20 20 1 0,000 9,999 -9,999
2 2 0.4 1 No dilution 0,000 0,000 0 0,000 9,999 -9,999
3 3 1.22 1 No dilution 0,000 0,000 0 0,000 9,999 -9,999
4 4 2.62 1 No dilution 0,000 0,000 0 0,000 9,999 -9,999
5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
6 No dilution 0,000 0,000 0 0,000 9,999 -9,999
7 No dilution 0,000 0,000 0 0,000 9,999 -9,999
8 No dilution 0,000 0,000 0 0,000 9,999 -9,999
9 No dilution 0,000 0,000 0 0,000 9,999 -9,999
February 2006/2
APOLIPOPROTEIN B FS
Cat. No 1 7112.........
Notes 1. Please refer to the package insert for Apoliporotein B FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name APO B
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 340
R1 diluent vol 0 S-wave.L
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. MSTD
Sample Vol (S) 1 Qualit. Judge Not do
Sample Vol (U) 1 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 41
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 17
Sample Type Serum S-DET.P.r 18
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1 Serum reac.smp.vol (u) 1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
Standard settings MULTI-STD
Formula Logit Log 3 Axis conv No convert
Blank passes Points 5
Pos. FV Reac.smp.vol.
Dil. Method Dil.smp.vol.
Diluent volume
Diluent posit.
Diluent volume
STD H STD L
BLK 1 0 1 No dilution 0,000 0,000 0 0,000 9,999 -9,999
1 2 0.2 1 A dilution 20 20 1 0,000 9,999 -9,999
2 2 0.4 1 No dilution 0,000 0,000 0 0,000 9,999 -9,999
3 3 1.27 1 No dilution 0,000 0,000 0 0,000 9,999 -9,999
4 4 2.54 1 No dilution 0,000 0,000 0 0,000 9,999 -9,999
5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
6 No dilution 0,000 0,000 0 0,000 9,999 -9,999
7 No dilution 0,000 0,000 0 0,000 9,999 -9,999
8 No dilution 0,000 0,000 0 0,000 9,999 -9,999
9 No dilution 0,000 0,000 0 0,000 9,999 -9,999
February 2008/1
Bicarbonate FS
Cat. No 1 0950.........
Notes 1. Please refer to the package insert Bicarbonate FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name CO2
R2e volume 0 Digits 1
R2 volume 0 M-wave L. 410
R1 diluent vol 0 S-wave.L 505
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1.1 Qualit. Judge Not do
Sample Vol (U) 1.1 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 36
Reagent 2 stir Weak M-DET.P.n 38
Reaction time 10 S-DET.P.p 3
Sample Type Serum S-DET.P.r 4
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1.1 Reac.typ Decrease
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u)
Diluent volume from RPP 0,000 Blank (d)
Sample Type Urine Sample (u)
Dilution specification Do Sample (d)
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1.1 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1.1 Serum reac.smp.vol (u) 1.1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2.2 Serum reac.smp.vol (u) 2.2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
November 2008/1
Bilirubin Auto Direct FS
Cat. No 1 0821.........
Notes 1. Please refer to the package insert for Bilirubin Auto Direct FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name DBIL
R2e volume 0 Digits 1
R2 volume 20 M-wave L. 545
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 6 Qualit. Judge Not do
Sample Vol (U) 6 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 18
Sample Type Serum S-DET.P.r 19
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 6 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u)
Diluent volume from RPP 0,000 Blank (d)
Sample Type Urine Sample (u)
Dilution specification Do Sample (d)
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 6 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 6 Serum reac.smp.vol (u) 6
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 10 Serum reac.smp.vol (u) 10
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
November 2008/1
May 2009/2
Bilirubin Auto Total FS
Cat. No 1 0811.........
Notes 1. Please refer to the package insert for Bilirubin Auto Total FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name TBIL
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 545
R1 diluent vol 0 S-wave.L 658
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 2 Qualit. Judge Not do
Sample Vol (U) 2 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 39
Reagent 2 stir Weak M-DET.P.n 40
Reaction time 10 S-DET.P.p 16
Sample Type Serum S-DET.P.r 18
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 2 Reac.typ Inc.
Diluent method No dilution Cykle 3
Undiluted sample volume 0 Factor 3
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9.999
Diluent volume from RPP 0,000 Blank (d) -9.999
Sample Type Urine Sample (u) 9.999
Dilution specification Do Sample (d) -9.999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 2 Re.absorb (u) 1.200
Diluent method No dilution Re.absorb (d) -9.999
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 10 Serum reac.smp.vol (u) 10
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
May 2009/2
APLICAÇÕES Advia 1200
CÁLCIO DIASYS
Analytical conditions
R1 volume 100.0 Sub Param. 46 1 Up Down
R2e volume 0.00 Sub-analy-conditions Standards setting
R3 volume 0.00 Name Ca FV *** BLK-L -9.999 STD H -9.999 Multi-STD Setting
Digits 1 BLK-H 9.9999 STD L 9.9999 Error judge rare
R1 Extra vol H-wave.L. 658nm
R2 Extra vol S-wave.L. *******
R3 Extra vol Anal.mthd EPA
R1 diluent vol 0.00 Calc.mthd STD
R2e diluent vol 0.00
Quali.judg Not do
R3 diluent vol 0.00 CCalculation method setting
Sample Vol( S ) 1,0 M-DET.P.1 0 S-DETP.p. 0 Reac.typ Inc
Sample vol (U) 1,0 Qualit. Judgment set M-DET.P.m 18 S-DET.P.r 0 Reaction rate method
Real time correct form M-DET.P.n 19 Cycle 2
Reanalysis conditions Check D.P.I 0 Factor 2.0
Rerun conditions set Limit value 0.003 E2 corre Not do
Reagent 1 stir Weak Mark setting Variance 10.0 Blank(µ) 9.9999
Reagent 2e stir Weak Normal Value setting * Prozone Blank(d) -9.9999
Reagent 2 stir Weak Abnormal value setting Prozone form None Sample(µ) 9.9999
Reaction Time 10 min. Prozone limit 9.999 Sample
(d)
-9.9999
Prozone judge Upper limit
Anaysis item
Condition setting (M)
Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
IMA setting
Setting
Allowance
Método: Arsenazo
Valor de Referência: 8,6 – 10,3 mg/dL
Linearidade: 25 mg/dL
Apresentação: 4 x 25 mL Rendimento 1014 testes
APLICAÇÕES Advia 1200
CKMB DIASYS
Analytical conditions
R1 volume 80.00 Sub Param. 46 1 Up Down
R2e volume 0.00 Sub-analy-conditions Standards setting
R3 volume 20.00 Name CKMB FV *** BLK-L -9.999 STD H -9.999 Multi-STD Setting
Digits 0 BLK-H 9.9999 STD L 9.9999 Error judge rare
R1 Extra vol H-wave.L. 340nm
R2 Extra vol S-wave.L. 410nm
R3 Extra vol Anal.mthd RRA
R1 diluent vol 0.00 Calc.mthd ABS
R2e diluent vol 0.00
Quali.judg Not do
R3 diluent vol 0.00 CCalculation method setting
Sample Vol( S ) 4,0 M-DET.P.1 0 S-DETP.p. 0 Reac.typ Inc
Sample vol (U) 4,0 Qualit. Judgment set M-DET.P.m 28 S-DET.P.r 0 Reaction rate method
Real time correct form M-DET.P.n 40 Cycle 2
Reanalysis conditions Check D.P.I 0 Factor 2.0
Rerun conditions set Limit value 0.003 E2 corre Not do
Reagent 1 stir Weak Mark setting Variance 10.0 Blank(µ) 9.9999
Reagent 2e stir Weak Normal Value setting * Prozone Blank(d) -9.9999
Reagent 2 stir Weak Abnormal value setting Prozone form None Sample(µ) 9.9999
Reaction Time 10 min. Prozone limit 9.999 Sample
(d)
9.9999
Prozone judge Upper limit
Anaysis item
Condition setting (M)
Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
IMA setting
Setting
Allowance
Método: UV Otimizado - DGKC
Valor de Referência< 24 U/L
Linearidade: 200 U/L
Apresentação: 4 x 20 mL
1 x 20 mL Rendimento 594 testes
APLICAÇÕES Advia 1200
CK DIASYS
Analytical conditions
R1 volume 80.00 Sub Param. 46 1 Up Down
R2e volume 0.00 Sub-analy-conditions Standards setting
R3 volume 20.00 Name CKNAC FV 4600 BLK-L -9.999 STD H -9.999 Multi-STD Setting
Digits 0 BLK-H 9.9999 STD L 9.9999 Error judge rare
R1 Extra vol H-wave.L. 340nm
R2 Extra vol S-wave.L. 410nm
R3 Extra vol Anal.mthd RRA
R1 diluent vol 0.00 Calc.mthd ABS
R2e diluent vol 0.00
Quali.judg Not do
R3 diluent vol 0.00 CCalculation method setting
Sample Vol( S ) 4,0 M-DET.P.1 0 S-DETP.p. 0 Reac.typ Inc
Sample vol (U) 4,0 Qualit. Judgment set M-DET.P.m 25 S-DET.P.r 0 Reaction rate method
Real time correct form M-DET.P.n 42 Cycle 2
Reanalysis conditions Check D.P.I 0 Factor 2.0
Rerun conditions set Limit value 0.003 E2 corre Not do
Reagent 1 stir Weak Mark setting Variance 10.0 Blank(µ) 0,5400
Reagent 2e stir Weak Normal Value setting * Prozone Blank(d) 0,1300
Reagent 2 stir Weak Abnormal value setting Prozone form None Sample(µ) 1,2100
Reaction Time 5 min. Prozone limit 9.999 Sample
(d)
0,1300
Prozone judge Upper limit
Anaysis item
Condition setting (M)
Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
IMA setting
Setting
Allowance
Método: UV Otimizado – DGKC e IFCC
Valor de Referência: M: < 145 U
H: < 171 U/L
Linearidade: 1000 U/L
Apresentação: 5 x 20 mL
1 x 25 mL Rendimento 740 testes
APLICAÇÕES Advia 1200
CLORO DIASYS
Analytical conditions
R1 volume 100.0 Sub Param. 46 1 Up Down
R2e volume 0.00 Sub-analy-conditions Standards setting
R3 volume 0.00 Name Clor FV *** BLK-L -9.999 STD H -9.999 Multi-STD Setting
Digits 0 BLK-H 9.9999 STD L 9.9999 Error judge rare
R1 Extra vol H-wave.L. 451nm
R2 Extra vol S-wave.L. ******
R3 Extra vol Anal.mthd EPA
R1 diluent vol 0.00 Calc.mthd STD
R2e diluent vol 0.00
Quali.judg Not do
R3 diluent vol 0.00 CCalculation method setting
Sample Vol( S ) 1,0 M-DET.P.1 0 S-DETP.p. 0 Reac.typ Inc
Sample vol (U) 1,0 Qualit. Judgment set M-DET.P.m 18 S-DET.P.r 0 Reaction rate method
Real time correct form M-DET.P.n 19 Cycle 3
Reanalysis conditions Check D.P.I 0 Factor 3.0
Rerun conditions set Limit value 0.003 E2 corre Not do
Reagent 1 stir Weak Mark setting Variance 10.0 Blank(µ) 9.9999
Reagent 2e stir Weak Normal Value setting * Prozone Blank(d) -9.9999
Reagent 2 stir Weak Abnormal value setting Prozone form None Sample(µ) 9.9999
Reaction Time 5 min. Prozone limit 9.999 Sample
(d)
-9.9999
Prozone judge Upper limit
Anaysis item
Condition setting (M)
Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
IMA setting
Setting
Allowance
Método: Colorimétrico - Tiocianato
Valor de Referência: 95 – 105 mEq/L
Linearidade: 130 mEq/L
Apresentação : 5 x 25 mL Rendimento 1014 testes
February 2006/2
CHOLESTEROL FS
Cat. No 1 1300.........
Notes 1. Please refer to the package insert for Cholesterol FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name CHOL
R2e volume 0 Digits 2
R2 volume 0 M-wave L. 505
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1.1 Qualit. Judge Not do
Sample Vol (U) 1.1 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1.1 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1.1 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1.1 Serum reac.smp.vol (u) 1.1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2.2 Serum reac.smp.vol (u) 2.2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
February 2008/1
Cholinesterase FS
Cat. No 1 1401.........
Notes 1. Please refer to the package insert for Cholinesterase FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name CHE
R2e volume 0 Digits 0
R2 volume 20 M-wave L. 410
R1 diluent vol 0 S-wave.L
R2e diluent vol 0 Analy.Methd. RRA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1.5 Qualit. Judge Not do
Sample Vol (U) 1.5 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 21
Reagent 2e stir Weak M-DET.P.m 24
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1.5 Reac.typ Decrease
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u)
Diluent volume from RPP 0,000 Blank (d)
Sample Type Urine Sample (u)
Dilution specification Do Sample (d)
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1.5 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1 Serum reac.smp.vol (u) 1.5
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 3 Serum reac.smp.vol (u) 3
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
CREATININE FS
Cat. No 1 1711.........
Notes 1. Please refer to the package insert for Creatinine FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name CREAT
R2e volume 0 Digits 2
R2 volume 25 M-wave L. 505
R1 diluent vol 0 S-wave.L 571
R2e diluent vol 0 Analy.Methd. RRA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 5 Qualit. Judge Not do
Sample Vol (U) 5 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 21
Reagent 2e stir Weak M-DET.P.m 26
Reagent 2 stir Weak M-DET.P.n 32
Reaction time 10 S-DET.P.p 14
Sample Type Serum S-DET.P.r 18
Dilution specification Do Check D.P.I. 21
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 5 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Do
Diluent position 0 Blank (u) 0.12
Diluent volume from RPP 0,000 Blank (d) 0.0240
Sample Type Urine Sample (u) 0.5
Dilution specification Do Sample (d) 0.024
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 5 Re.absorb (u)
Diluent method A dilution Re.absorb (d)
Undiluted sample volume 5 Rerun conditions set
Diluent volume 245 Absorbance limit (u) D1
Diluent position 1 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 5 Serum reac.smp.vol (u) 5
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 2
Diluent volume 40 Diluent volume 250
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 10 Serum reac.smp.vol (u) 5
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
Application Advia 1200/C July 2011/3
Creatinine PAP FS ADVIA 1200/2400
Order information Cat. No. 1 1759 99 10 950 Chemistry code – 79 175
Notes 1. Please refer to the package insert for Creatinine PAP FS for detailed information about the test on the following: Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity / Interferences / Sensitivity / Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature 2. The stability of the reagent on board the analyser is 6 weeks provided that contamination and evaporation are avoided. 3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany. This application was set up and evaluated by DiaSys. It is based on the standard equipment at that time and does not apply to any equipment modifications undertaken by the manufacturer or by other persons
June 2008/1
FERRITIN FS
Cat. No 1 7059.........
Notes 1. Please refer to the package insert for Ferritin FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name FERR
R2e volume 0 Digits 2
R2 volume 40 M-wave L. 571
R1 diluent vol 0 S-wave.L 805
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. MSTD
Sample Vol (S) 4 Qualit. Judge Not do
Sample Vol (U) 4 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 33
Reagent 2 stir Weak M-DET.P.n 34
Reaction time 10 S-DET.P.p 22
Sample Type Serum S-DET.P.r 22
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 4 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 4 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1 Serum reac.smp.vol (u) 4
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 4 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 8 Serum reac.smp.vol (u) 8
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
June 2008/1
Standard settings MULTI-STD
Formula Spline Axis conv No convert
Blank passes Points 5
Pos. FV Reac.smp.vol.
Dil. Method Dil.smp.vol.
Diluent volume
Diluent posit.
Diluent volume
STD H STD L
BLK 1 0 4 No dilution 0,000 0,000 0 0,000 9,999 -9,999
1 2 100 4 No dilution 0,000 0,000 0 0,000 9,999 -9,999
2 3 200 4 No dilution 0,000 0,000 0 0,000 9,999 -9,999
3 4 500 4 No dilution 0,000 0,000 0 0,000 9,999 -9,999
4 5 1000 4 No dilution 0,000 0,000 0 0,000 9,999 -9,999
5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
6 No dilution 0,000 0,000 0 0,000 9,999 -9,999
7 No dilution 0,000 0,000 0 0,000 9,999 -9,999
8 No dilution 0,000 0,000 0 0,000 9,999 -9,999
9 No dilution 0,000 0,000 0 0,000 9,999 -9,999
May 2009/3
IRON FS Ferene
Cat. No 1 1911.........
Notes 1. Please refer to the package insert for Iron FS Ferene for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name FE
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 596
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 5 Qualit. Judge Not do
Sample Vol (U) 5 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 18
Sample Type Serum S-DET.P.r 19
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 5 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u)
Diluent volume from RPP 0,000 Blank (d)
Sample Type Urine Sample (u)
Dilution specification Do Sample (d)
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 5 Re.absorb (u) 9.999
Diluent method No dilution Re.absorb (d) -9.999
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 5 Serum reac.smp.vol (u) 5
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 10 Serum reac.smp.vol (u) 10
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
May 2009/3
APLICAÇÕES Advia 1200
FOSFATASE ALCALINA DIASYS
Analytical conditions
R1 volume 80.00 Sub Param. 46 1 Up Down
R2e volume 0.00 Sub-analy-conditions Standards setting
R3 volume 20.00 Name ALPD
FV
4550 BLK-L -9.999 STD H -9.999 Multi-STD Setting
Digits 0 BLK-H 9.9999 STD L 9.9999 Error judge rare
R1 Extra vol H-wave.L. 410nm
R2 Extra vol S-wave.L. 478nm
R3 Extra vol Anal.mthd RRA
R1 diluent vol 0.00 Calc.mthd ABS
R2e diluent vol 0.00
Quali.judg Not do
R3 diluent vol 0.00 CCalculation method setting
Sample Vol( S ) 1,6 M-DET.P.1 21 S-DETP.p. 0 Reac.typ Inc
Sample vol (U) 1,6 Qualit. Judgment set M-DET.P.m 25 S-DET.P.r 0 Reaction rate method
Real time correct form M-DET.P.n 42 Cycle 2
Reanalysis conditions Check D.P.I 21 Factor 2.0
Rerun conditions set Limit value 0.003 E2 corre Not do
Reagent 1 stir Weak Mark setting Variance 10.0 Blank(µ) 0,6000
Reagent 2e stir Weak Normal Value setting * Prozone Blank(d) 0,0200
Reagent 2 stir Weak Abnormal value setting Prozone form None Sample(µ) 1,1770
Reaction Time 10 min. Prozone limit 9.999 Sample
(d)
0,0200
Prozone judge Upper limit
Anaysis item
Condition setting (M)
Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
IMA setting
Setting
Allowance
Método: Enzimático colorinmétrico - IFCC
Linearidade: 1200 U/L
Apresentação: 5 x 20 mL
1 x 25 mL Rendimento 740 Testes
Valor de Referência:
Adultos
Homens 20 a 50 anos 53 – 128 U/L
Homens > 60 anos 56 – 119 U/L
Mulheres 20 a 50 anos 42 – 98 U/L
Mulheres > 60 anos 53 – 141 U/L
Crianças
Unidade Mulheres Homens
1 – 30 dias U/L 48 – 406 75 – 319
1 mes – 1 ano U/L 124 – 341 82 – 383
1 – 3 anos U/L 108 – 317 104 – 345
4 – 6 anos U/L 96 – 297 93 – 309
7 – 9 anos U/L 69 – 325 86 – 315
10 – 12 anos U/L 51 – 332 42 – 362
13 – 15 anos U/L 50 – 162 74 – 390
16 – 18 anos U/L 47 - 119 52 – 171
May 2009/3
GAMMA GT FS (Szasz mod.)
Cat. No 1 2801.........
Notes 1. Please refer to the package insert for Gamma-GT FS (Szasz mod.) for detailed information about the test on the
following: Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name GGT
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 410
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. RRA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 3 Qualit. Judge Not do
Sample Vol (U) 3 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 21
Reagent 2e stir Weak M-DET.P.m 24
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 21
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 3 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Do
Diluent position 0 Blank (u) 1.47
Diluent volume from RPP 0,000 Blank (d) 0.39
Sample Type Urine Sample (u) 1.74
Dilution specification Do Sample (d) 0.39
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 3 Re.absorb (u) 10.000
Diluent method No dilution Re.absorb (d) -9.999
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1 Serum reac.smp.vol (u) 3
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 6 Serum reac.smp.vol (u) 6
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
May 2009/3
November 2008/1
Glucose GOD FS
Cat. No 1 2500.........
Notes 1. Please refer to the package insert for Glucose GOD FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name GLUC
R2e volume 0 Digits 2
R2 volume 0 M-wave L. 505
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1.1 Qualit. Judge Not do
Sample Vol (U) 1.1 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1.1 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1.1 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1.1 Serum reac.smp.vol (u) 1.1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2.2 Serum reac.smp.vol (u) 2.2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
November 2008/1
March 2008/3
oneHbA1c FS
Cat. No 1 3329.........
Notes 1. Please refer to the package insert for oneHbA1c FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name HbA1c
R2e volume 0 Digits 2
R2 volume 40 M-wave L. 658
R1 diluent vol 0 S-wave.L None
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. MSTD
Sample Vol (S) 2.0 Qualit. Judge Not do
Sample Vol (U) 2.0 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 41
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Haem S-DET.P.r 0
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 2.0 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 1 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction 0 Prozone 0
Liquid volume correction 0 Endpoint method
Reaction sample volume 2.0 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Haem Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 2.0 Serum reac.smp.vol (u) 2.0
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 4.0 Serum reac.smp.vol (u) 4.0
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
March 2008/3
Standard settings MULTI-STD
Formula Spline Axis conv No convert
Blank passes Points 5
Pos. FV Reac.smp.vol.
Dil. Method Dil.smp.vol.
Diluent volume
Diluent posit.
Diluent volume
STD H STD L
BLK 0 2 No dilution 0,000 0,000 1 0,000 9,999 -9,999
1 2.23 2 No dilution 0,000 0,000 1 0,000 9,999 -9,999
2 6.48 2 No dilution 0,000 0,000 1 0,000 9,999 -9,999
3 8.71 2 No dilution 0,000 0,000 1 0,000 9,999 -9,999
4 12.5 2 No dilution 0,000 0,000 1 0,000 9,999 -9,999
5 No dilution 0,000 0,000 0 0,000 9,999 -9,999
6 No dilution 0,000 0,000 0 0,000 9,999 -9,999
7 No dilution 0,000 0,000 0 0,000 9,999 -9,999
8 No dilution 0,000 0,000 0 0,000 9,999 -9,999
9 No dilution 0,000 0,000 0 0,000 9,999 -9,999
February 2006/2
HDL-C IMMUNO FS
Cat. No 1 3521.........
Notes 1. Please refer to the package insert for HDL-C Immuno FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
. **This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name HDL
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 596
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1 Qualit. Judge Not do
Sample Vol (U) 1 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 17
Sample Type Serum S-DET.P.r 18
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1 Serum reac.smp.vol (u) 1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
February 2006/2
LACTATE FS
Cat. No 1 4001.........
Notes 1. Please refer to the package insert for Lactate FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name LACT
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 340
R1 diluent vol 0 S-wave.L
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1.3 Qualit. Judge Not do
Sample Vol (U) 1.3 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 41
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 17
Sample Type Serum S-DET.P.r 18
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1.3 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u)
Diluent volume from RPP 0,000 Blank (d)
Sample Type Urine Sample (u)
Dilution specification Do Sample (d)
Dilution correction Not Do
Liquid volume correction Not Do Endpoint method
Reaction sample volume 1.3 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1.3 Serum reac.smp.vol (u) 1.3
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2.6 Serum reac.smp.vol (u) 2.6
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
May 2009/3
LDH DGKC FS
Cat. No 1 4201......... Notes 1. Please refer to the package insert for LDH DGKC FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name LDH
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 340
R1 diluent vol 0 S-wave.L 410
R2e diluent vol 0 Analy.Methd. RRA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 3 Qualit. Judge Not do
Sample Vol (U) 3 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 21
Reagent 2e stir Weak M-DET.P.m 26
Reagent 2 stir Weak M-DET.P.n 39
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 21
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 3 Reac.typ Dec.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Do
Diluent position 0 Blank (u) 0.6200
Diluent volume from RPP 0,000 Blank (d) 0.110
Sample Type Urine Sample (u) 1.1100
Dilution specification Do Sample (d) 0.110
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 3 Re.absorb (u) 10.000
Diluent method No dilution Re.absorb (d) -9.999
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 3 Serum reac.smp.vol (u) 3
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 6 Serum reac.smp.vol (u) 6
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
LDL-C SELECT FS
Cat. No 1 4121.........
Notes 1. Please refer to the package insert for LDL-C Select FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
. **This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name LDL
R2e volume 0 Digits 2
R2 volume 20 M-wave L. 596
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1 Qualit. Judge Not do
Sample Vol (U) 1 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 17
Sample Type Serum S-DET.P.r 18
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1 Serum reac.smp.vol (u) 1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
APLICAÇÕES 1200
Lipase - DiaSys
Analytical conditions
R1 volume 100.0 Sub Param. 46 - 1 Up Down Standards setting
R2 volume 0.00 Sub-analy-conditions BLK H 9.99999 Multi-STD Abnml (serum)H 1500
R3 volume 25.0 Nam
e
Lipase Digits 1 BLK-L -9.9999 Abnml (serum)L 0.0
R4 volume 0.00 H-wave.L. 571nm STD H 9.99999
R1 diluent vol 0.00 S-wave.L. 694nm STD L -9.9999
R2 diluent vol 0.00 Analy.mth
d
RRA FV 84,0 Normal value set
* 1
R3 diluent vol 0.00 Calc.
mthd
STD
R4 diluent vol 0.00
Qualit.jud
g
Not do Quality.set
Serum
reac.s.vol.
2,0 Real-time correct.
Form
CCalculation method setting
Serum dil.
method.
Reanalysis conditions M-DET.P.1 22 S-DETP.p. 0
Serum dil.s.vol. Serum reac.smp.vol.
(µ)
2,0 M-DET.P.m 24 S-DET.P.r 0 Reaction rate method
erum dil. volume Serum dilute.method
(µ)
Spe M-DET.P.n 41 Cycle 3
Serum dil. posit. 0 Serum dil.emp.vol. (µ) 15,0 Check D.P.I 21 Factor 1,2
Urine set Serum diluente vol (µ) 120,0 Limit value 0.003 Reac.typ Inc
Reaction time 10 min Serum diluent posi (µ) 0 Variance 10.0 E2 corre Not do
Reagent 1 stir Weak Serum reac.smp.vol (d) ----- * Prozone Blank(µ) 9.999
Reagent 2 stir Weak Serum dilut.method (d) ------- Prozone form None Blank(d) -9.9999
Reagent 3 stir Weak Serum dil.emp.vol.(d) ------ Prozone limit 9.999 Sample (µ) 9.999
Reagent 4 stir Weak Serum diluent vol (d) ------ Prozone judge Upper limit Sample (d) -9.9999
Serum diluent posi (d) 0 Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
Urine set Rerun.cond. IMA setting
* 1 Normal value set : Soro : < 190 U/L
February 2006/2
MAGNESIUM XL FS
Cat. No 1 4610.........
Notes 1. Please refer to the package insert for Magnesium XL FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name MG
R2e volume 0 Digits 2
R2 volume 0 M-wave L. 545
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1 Qualit. Judge Not do
Sample Vol (U) 1 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1 Re.absorb (u)
Diluent method A dilution Re.absorb (d)
Undiluted sample volume 10 Rerun conditions set
Diluent volume 40 Absorbance limit (u) D1
Diluent position 1 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1 Serum reac.smp.vol (u) 1
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 10
Diluent volume 40 Diluent volume 90
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
February 2006/2
February 2006/2
CRP U-hs High sensitive (hs) application
Cat. No 1 7045.........
Notes 1. Please refer to the package insert for CRP U-hs for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 50 Name CRP-Hs
R2e volume 0 Digits 2
R2 volume 50 M-wave L. 505
R1 diluent vol 0 S-wave.L 694
R2e diluent vol 0 Analy.Methd. 2PA
R2 diluent vol 0 Calc.Methd. MSTD
Sample Vol (S) 5 Qualit. Judge Not do
Sample Vol (U) 5 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 27
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1 Reac.typ Inc.
Diluent method A dilution Cykle 2
Undiluted sample volume 30 Factor 2
Diluent volume 90 E2 corr Not Do
Diluent position 1 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do Prozone Prozone formula
Liquid volume correction Do Prozone Limit
Reaction sample volume 5 Prozone Judge Upper Limit
Diluent method A dilution Judge Limit 9.999
Undiluted sample volume 30 M-DET.P.m
Diluent volume 90 M-DET.P.n
Diluent position 1 S-DET.P.p 0
Diluent volume from RPP 0,000 S-DET.P.r 0
Rerun Conditions Set Endpoint Method
Absorbance limit (u) D1 Re.absorb (u) 0.697
Absorbance limit (d) D2 Re.absorb (d) 0.074
Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 5 Serum reac.smp.vol (u) 5
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 5 Serum reac.smp.vol (u) 5
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
February 2006/2
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 3 Dilute 3
Serum reac.smp.vol (u) 10 Serum reac.smp.vol (u) 10
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 10 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
Standard settings MULTI-STD
Formula Logit Log 3 Axis conv No convert
Blank passes Points 6
Pos. FV Reac.smp.vol.
Dil. Method Dil.smp.vol.
Diluent volume
Diluent posit.
Diluent volume
STD H STD L
BLK 1 0 10 No dilution 0,000 0,000 0 0,000 9,999 -9,999
1 * 0.5 10 A dilution 30 90 1 0,000 9,999 -9,999
2 * 2.45 10 A dilution 30 90 1 0,000 9,999 -9,999
3 * 8.45 10 A dilution 30 90 1 0,000 9,999 -9,999
4 * 12.4 10 A dilution 30 90 1 0,000 9,999 -9,999
5 * 20.4 10 A dilution 30 90 1 0,000 9,999 -9,999
6 No dilution 0,000 0,000 0 0,000 9,999 -9,999
7 No dilution 0,000 0,000 0 0,000 9,999 -9,999
8 No dilution 0,000 0,000 0 0,000 9,999 -9,999
9 No dilution 0,000 0,000 0 0,000 9,999 -9,999
February 2006/2
CRP U-hs Universal (U) application
Cat. No 1 7045.........
Notes 1. Please refer to the package insert for CRP U-hs for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 50 Name CRP-U
R2e volume 0 Digits 2
R2 volume 50 M-wave L. 505
R1 diluent vol 0 S-wave.L 805
R2e diluent vol 0 Analy.Methd. 2PA
R2 diluent vol 0 Calc.Methd. MSTD
Sample Vol (S) 2 Qualit. Judge Not do
Sample Vol (U) 2 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 27
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 1 Reac.typ Inc.
Diluent method A dilution Cykle 2
Undiluted sample volume 10 Factor 2
Diluent volume 140 E2 corr Not Do
Diluent position 1 Blank (u) 9,999
Diluent volume from RPP 0,000 Blank (d) -9,999
Sample Type Urine Sample (u) 9,999
Dilution specification Do Sample (d) -9,999
Dilution correction Do Prozone Prozone formula
Liquid volume correction Do Prozone Limit
Reaction sample volume 2 Prozone Judge Upper Limit
Diluent method A dilution Judge Limit 9.999
Undiluted sample volume 10 M-DET.P.m
Diluent volume 140 M-DET.P.n
Diluent position 1 S-DET.P.p 0
Diluent volume from RPP 0,000 S-DET.P.r 0
Rerun Conditions Set Endpoint Method
Absorbance limit (u) D1 Re.absorb (u)
Absorbance limit (d) D2 Re.absorb (d)
Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
February 2006/2
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 3 Dilute 3
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 10 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
Standard settings MULTI-STD
Formula Logit Log 3 Axis conv No convert
Blank passes Points 6
Pos. FV Reac.smp.vol.
Dil. Method Dil.smp.vol.
Diluent volume
Diluent posit.
Diluent volume
STD H STD L
BLK 1 0 10 No dilution 0,000 0,000 0 0,000 9,999 -9,999
1 * 6 10 A dilution 10 140 1 0,000 9,999 -9,999
2 * 65 10 A dilution 10 140 1 0,000 9,999 -9,999
3 * 100 10 A dilution 10 140 1 0,000 9,999 -9,999
4 * 175 10 A dilution 10 140 1 0,000 9,999 -9,999
5 * 350 10 A dilution 10 140 1 0,000 9,999 -9,999
6 No dilution 0,000 0,000 0 0,000 9,999 -9,999
7 No dilution 0,000 0,000 0 0,000 9,999 -9,999
8 No dilution 0,000 0,000 0 0,000 9,999 -9,999
9 No dilution 0,000 0,000 0 0,000 9,999 -9,999
May 2009/2
Total Protein FS
Cat. No 1 2311.........
Notes 1. Please refer to the package insert for Total Protein FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name TPRO
R2e volume 0 Digits 1
R2 volume 25 M-wave L. 545
R1 diluent vol 0 S-wave.L 0
R2e diluent vol 0 Analy.Methd. EPA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 2 Qualit. Judge Not do
Sample Vol (U) 2 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 0
Reagent 2e stir Weak M-DET.P.m 40
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 18
Sample Type Serum S-DET.P.r 19
Dilution specification Do Check D.P.I. 0
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 2 Reac.typ Inc.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Not Do
Diluent position 0 Blank (u) 9.999
Diluent volume from RPP 0,000 Blank (d) -9.999
Sample Type Urine Sample (u) 9.999
Dilution specification Do Sample (d) -9.999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 2 Re.absorb (u) 9.999
Diluent method No dilution Re.absorb (d) -9.999
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 2 Serum reac.smp.vol (u) 2
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 10 Serum reac.smp.vol (u) 10
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
May 2009/2
APLICAÇÕES 1200
Proteína Urinária - Diasys
Analytical conditions
R1 volume 80.0 Sub Param. 46 - 1 Up Down Standards setting
R2 volume 0.00 Sub-analy-conditions BLK H 9.99999 Multi-STD Abnml (serum)H 300,0
R3 volume 0.00 Nam
e
PT u Digits 1 BLK-L -9.9999 Abnml (serum)L
Abnml (urine)H
0.0
300,0
R4 volume 0.00 H-wave.L. 596nm STD H 9.99999
R1 diluent vol 0.00 S-wave.L. ****nm STD L -9.9999
R2 diluent vol 0.00 Analy.mth
d
EPA FV ------ Normal value set
* 1
R3 diluent vol 0.00 Calc.
mthd
STD
R4 diluent vol 0.00
Qualit.jud
g
Not do Quality.set
Serum
reac.s.vol.
1,6 Real-time correct.
Form
CCalculation method setting
Serum dil.
method.
Reanalysis conditions M-DET.P.1 0 S-DETP.p. 0
Serum dil.s.vol. Serum reac.smp.vol.
(µ)
1,6 M-DET.P.m 20 S-DET.P.r 0 Reaction rate method
erum dil. volume Serum dilute.method
(µ)
Spe M-DET.P.n 21 Cycle 3
Serum dil. posit. 0 Serum dil.emp.vol. (µ) 15,0 Check D.P.I 0 Factor 3.0
Urine set Serum diluente vol (µ) 120,0 Limit value 0.003 Reac.typ Inc
Reaction time 10 min Serum diluent posi (µ) 0 Variance 10.0 E2 corre Not do
Reagent 1 stir Weak Serum reac.smp.vol (d) ----- * Prozone Blank(µ) 9.999
Reagent 2 stir Weak Serum dilut.method (d) ------- Prozone form None Blank(d) -9.9999
Reagent 3 stir Weak Serum dil.emp.vol.(d) ------ Prozone limit 9.999 Sample (µ) 9.999
Reagent 4 stir Weak Serum diluent vol (d) ------ Prozone judge Upper limit Sample (d) -9.9999
Serum diluent posi (d) 0 Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
Urine set Rerun.cond. IMA setting
Rendimento : 1184 testes
:
May 2009/2
ASAT(GOT) FS (IFCC mod.)
Cat. No 1 2601......... Notes 1. Please refer to the package insert for ASAT(GOT) FS (IFCC Mod.) for detailed information about the test on the
following: Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name ASAT
R2e volume 0 Digits 1
R2 volume 20 M-wave L. 340
R1 diluent vol 0 S-wave.L 410
R2e diluent vol 0 Analy.Methd. RRA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 8 Qualit. Judge Not do
Sample Vol (U) 8 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 22
Reagent 2e stir Weak M-DET.P.m 25
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 21
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 8 Reac.typ Dec.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Do
Diluent position 0 Blank (u) 2.000
Diluent volume from RPP 0,000 Blank (d) 0.721
Sample Type Urine Sample (u) 2.000
Dilution specification Do Sample (d) 0.690
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 8 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 8 Serum reac.smp.vol (u) 8
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 16 Serum reac.smp.vol (u) 16
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
May 2009/2
ALAT(GPT) FS (IFCC mod.)
Cat. No 1 2701......... Notes 1. Please refer to the package insert for ALAT(GPT) FS (IFCC Mod.) for detailed information about the test on the
following: Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 80 Name ALAT
R2e volume 0 Digits 1
R2 volume 20 M-wave L. 340
R1 diluent vol 0 S-wave.L 410
R2e diluent vol 0 Analy.Methd. RRA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 8 Qualit. Judge Not do
Sample Vol (U) 8 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 22
Reagent 2e stir Weak M-DET.P.m 25
Reagent 2 stir Weak M-DET.P.n 42
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 21
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 8 Reac.typ Dec.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Do
Diluent position 0 Blank (u) 2.000
Diluent volume from RPP 0,000 Blank (d) 0.771
Sample Type Urine Sample (u) 2.000
Dilution specification Do Sample (d) 0.690
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 8 Re.absorb (u)
Diluent method No dilution Re.absorb (d)
Undiluted sample volume 0 Rerun conditions set
Diluent volume 0,000 Absorbance limit (u) D1
Diluent position 0 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 8 Serum reac.smp.vol (u) 8
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 20
Diluent volume 40 Diluent volume 40
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 16 Serum reac.smp.vol (u) 16
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)
APLICAÇÕES Advia 1200
TRIGLICÉRIDES DIASYS
Analytical conditions
R1 volume 100.0 Sub Param. 46 1 Up Down
R2e volume 0.00 Sub-analy-conditions Standards setting
R3 volume 0.00 Name Trig FV *** BLK-L -9.999 STD H -9.999 Multi-STD Setting
Digits 0 BLK-H 9.9999 STD L 9.9999 Error judge rare
R1 Extra vol H-wave.L. 505nm
R2 Extra vol S-wave.L. 694nm
R3 Extra vol Anal.mthd EPA
R1 diluent vol 0.00 Calc.mthd STD
R2e diluent vol 0.00
Quali.judg Not do
R3 diluent vol 0.00 CCalculation method setting
Sample Vol( S ) 1,0 M-DET.P.1 0 S-DETP.p. 0 Reac.typ Inc
Sample vol (U) 1,0 Qualit. Judgment set M-DET.P.m 19 S-DET.P.r 0 Reaction rate method
Real time correct form M-DET.P.n 20 Cycle 2
Reanalysis conditions Check D.P.I 0 Factor 2.0
Rerun conditions set Limit value 0.003 E2 corre Not do
Reagent 1 stir Weak Mark setting Variance 10.0 Blank(µ) 9.9999
Reagent 2e stir Weak Normal Value setting * Prozone Blank(d) -9.9999
Reagent 2 stir Weak Abnormal value setting Prozone form None Sample(µ) 9.9999
Reaction Time 10 min. Prozone limit 9.999 Sample
(d)
9.9999
Prozone judge Upper limit
Anaysis item
Condition setting (M)
Judge limit 9.999 * Endpoint method
M-DET.P.m 0 S-DET.P.p 0 Re.absorb(µ) 9.9999
M-DET.P.n 0 S-DET.P.r 0 Re.absorb(d) -9.9999
IMA setting
Setting
Allowance
Metodologia: Colorimétrico Enzimático - GOP
Valor de Referência: Desejável: < 200 mg/dL
Limite alto: 200 a 400 mg/dL
Elevado: > 400 mg/dL
Linearidade: 1000 mg/dL
Apresentação : 5 x 25 mL Rendimento 1014 Testes
May 2009/2
UREA FS
Cat. No 1 3101.........
Notes 1. Please refer to the package insert for Urea FS for detailed information about the test on the following:
Clinical Relevance, Method and Principle, Composition and Stability of the Reagents, Specimens, Calibrators and Controls, Performance Characteristics regarding Measuring Range / Specificity/Interferences / Sensitivity/Limit of Detection / Precision (Reproducibility, Repeatability) / Method Comparison / Reference Ranges / Literature
2. The stability of the reagent on board the analyser is at least one month provided that contamination and evaporation are avoided.
3. Manufactured by: DiaSys Diagnostic Systems GmbH Alte Strasse 9, 65558 Holzheim, Germany.
**This application proposal is for guidelines only. To avoid misinterpretation measured results have to be validated and assessed with caution
Analytical conditions Sub-analy. conditions
R1 volume 100 Name UREA
R2e volume 0 Digits 1
R2 volume 25 M-wave L. 340
R1 diluent vol 0 S-wave.L 410
R2e diluent vol 0 Analy.Methd. RRA
R2 diluent vol 0 Calc.Methd. STD
Sample Vol (S) 1.2 Qualit. Judge Not do
Sample Vol (U) 1.2 Calculation method setting
Reagent 1 stir Weak M-DET.P.l 21
Reagent 2e stir Weak M-DET.P.m 24
Reagent 2 stir Weak M-DET.P.n 31
Reaction time 10 S-DET.P.p 0
Sample Type Serum S-DET.P.r 0
Dilution specification Do Check D.P.I. 21
Dilution correction Not Do Limit value 0,003
Liquid volume correction Not Do Variance 10
Reaction sample volume 5 Reac.typ Dec.
Diluent method No dilution Cykle 2
Undiluted sample volume 0 Factor 2
Diluent volume 0,000 E2 corr Do
Diluent position 0 Blank (u) 9.999
Diluent volume from RPP 0,000 Blank (d) -9.999
Sample Type Urine Sample (u) 9.999
Dilution specification Do Sample (d) -9.999
Dilution correction Do
Liquid volume correction Do Endpoint method
Reaction sample volume 1.2 Re.absorb (u) 10.000
Diluent method A dilution Re.absorb (d) -9.999
Undiluted sample volume 2 Rerun conditions set
Diluent volume 248 Absorbance limit (u) D1
Diluent position 1 Absorbance limit (d) D2
Diluent volume from RPP 0,000 Effect.nbr.o.pnts (n)
Abnormal val.limit (h) D1
Abnormal val.limit (l) D2
Reanalysis conditions
Sample Type Serum Sample Type Urine
Dilute 1 Dilute 1
Serum reac.smp.vol (u) 1.2 Serum reac.smp.vol (u) 1.2
Dilution method A dilution Dilution method A dilution
Undiluted sample volume 20 Undiluted sample volume 2
Diluent volume 40 Diluent volume 248
Diluent position 1 Diluent position 1
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Dilute 2 Dilute 2
Serum reac.smp.vol (u) 1.2 Serum reac.smp.vol (u) 1.2
Dilution method No dilution Dilution method No dilution
Undiluted sample volume 0 Undiluted sample volume 0
Diluent volume 0 Diluent volume 0
Diluent position 0 Diluent position 0
Diluent volume from RPP 0,000 Diluent volume from RPP 0,000
Abnormal value setting
Main Abnormal value (H1)
Main Abnormal value (L1)